维普中文期刊产品整合服务
16篇 您的检索式:作者名="Oratz R"
    题名 作者 年代 出处 被引量
1Paelitaxel-Induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration : Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment 显示文摘SYMMANS W F VOLM M D SHAPIRO R L PERKINS A B KIM A Y DEMARIA S YEE H T MCMULLEN H ORATZ R KLEIN P FORMENTI S C MUGGIA F 2000Clin Cancer Res2000,6,12:1
2Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine显示文摘Reynolds SR Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
3Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer显示文摘Oratz R Kim B Chao C 2011J Oncol Pract2011,7,2:1
4Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma显示文摘Oratz R Hauschild A 2003Melanoma Res2003,13,1:1
5Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma显示文摘Oratz R Hauschild A Schadendorf D 2003Melanoma Res2003,13,1:1
6Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine显示文摘 Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
7Stimulation of CD8 T cell responsesto MAGE-3 and Melan A/MART-I by immunization to a polyvalent melanoma vaccine显示文摘Reynolds SR Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
8Stimulation of CD8 + T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine 显示文摘 Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
9Phase Ⅱ trial of paelitaxel and cisplatin in women with advanced breast cancer:an active regimen with limiting neurotoxicity显示文摘Wasserheit C Frazein A Oratz R 1996J Clin Oncol1996,14,7:1
10Stimulation of CD8+T cell responses to MAGE-3 and Melan A/MART- 1 by immunization to a polyvalent melanoma vaccine显示文摘Reynolds SR Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
11Elective radiation therapy for high-risk malignant melanomas显示文摘Cooper JS Chang WS Oratz R 2001Cancer J2001,7,6:1
12Double-blind trial of a polyvalent,shed-antigen,melanoma vaccine显示文摘Bystryn J C Zeleniuch-Jacquotte A Oratz R 2009Clin Cancer Res2009,7,7:1
13Phase Ⅱ trial of daearbazine and thalidomide for the treatment of metastatic melanoma 显示文摘Ott PA Chang JL Oratz R 2009Chemotherapy2009,55,4:1
14Stimulation of CD8 T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine显示文摘Reynolds SR Oratz R Shapiro RL 1997Int J Cancer1997,72,6:1
15Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma 显示文摘Ott PA Chang JL Oratz R 2009Chemotherapy2009,55,4:1
16恶性黑素瘤的免疫疗法显示文摘体液及细胞免疫对控制人体恶性黑素瘤的生长具有重要作用,因此有希望通过调节免疫机制达到治疗甚至预防目的。本文重点讨论了卡介苗、白细胞介素2、淋巴因子激活的杀伤细胞、单克隆抗体、肿瘤疫苗、干扰素等免疫调节剂抗恶性黑素瘤的作用机制、疗效及毒副作用。认为免疫治疗最适宜用于Ⅰ期、Ⅱ期(肿瘤组织已被切除)恶性黑素瘤,对已发生转移的Ⅲ期恶性黑素瘤,被动使用效应因子(抗体、免疫细胞)有效。Oratz R 崔盘根 1993国外医学(皮肤性病学分册)1993,19,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费